Community

Our community narratives are driven by numbers and valuation.

Value any stock for free in seconds

Get alerts and valuation updates

Participate in discussions

Weekly Picks

Silo Pharma

CMCVentures

Community Contributor

Groundbreaking therapies that could change the treatment landscape for PTSD, fibromyalgia, MS & Alzheimer’s

Key Takeaways Silo Pharma is advancing a diversified pipeline of innovative therapies aimed at major health challenges in Central Nervous System (CNS) disorders like PTSD, fibromyalgia, Alzheimer’s, and multiple sclerosis (MS). The company’s unique approach of combining traditional drugs with psychedelic-inspired therapies positions it to address significant gaps in the treatment landscape.

View narrative

US$6.20

86.8% undervalued

234.00%

Revenue growth p.a.

7 days ago

DigitalOcean Holdings

Nenad

Community Contributor

DigitalOcean Will Grow 14% by Embracing AI with Paperspace Acquisition

1. Current Business (Present Narrative): DigitalOcean is a cloud computing provider focused on small and medium-sized businesses (SMBs) , startups, and developers.

View narrative

US$50.00

43.5% undervalued

18.62%

Revenue growth p.a.

4 months ago

Viant Technology

BlackGoat

Community Contributor

Viant Technology: A Rising AdTech Challenger in the AI-Powered CTV Market

Summary: A High-Growth AI-Driven AdTech Play AI-powered, high-growth mid-cap stock in the digital ad space with strong long-term upside potential. Booming CTV Market Opportunity: $60B+ in TV ad budgets are shifting to Connected TV (CTV), and Viant (DSP) is positioned to capture market share.

View narrative

US$38.61

61.4% undervalued

13.00%

Revenue growth p.a.

1 day ago

Load previous narratives

Gevo

AnalystConsensusTarget

Consensus Narrative from 3 Analysts

DOE Backed Ethanol-to-Jet And SaaS Projects Will Build Future Value

Key Takeaways Transformative acquisitions and partnerships are expected to boost net margins and revenue through carbon monetization and lower production costs. Strategic projects and technology advancements aim to increase earnings by leveraging tax credits and expanding into new revenue streams.

View narrative

US$5.45

81.3% undervalued

126.06%

Revenue growth p.a.

6 days ago

VNET Group

AnalystConsensusTarget

Consensus Narrative from 12 Analysts

High-Performance Data Centers And AI Demand Will Fuel Success

Key Takeaways VNET's substantial order wins in cloud and AI sectors boost revenue potential, while JV structures aim to optimize capital efficiency and margins. AI-driven demand sustains high-performance data center growth, with supply shortages in Tier 1 cities potentially enhancing pricing and net margins.

View narrative

US$14.96

54.3% undervalued

16.90%

Revenue growth p.a.

6 days ago

South32

AnalystConsensusTarget

Consensus Narrative from 14 Analysts

Worsley Approvals And GEMCO Restart Will Strengthen Mining Operations

Key Takeaways The Worsley Mine Project and GEMCO restart promise future revenue growth and improved operating margins, backed by recent approvals and phased mining activities. Focused cost management and critical mineral projects are set to enhance net margins and cash flows, supporting future earnings growth.

View narrative

AU$3.56

20.0% undervalued

5.93%

Revenue growth p.a.

6 days ago

Clover Health Investments

AnalystConsensusTarget

Consensus Narrative from 4 Analysts

Tech-Driven Care And Home Services Will Secure Long-Term Success

Key Takeaways Enhanced star ratings will increase future revenue and provide long-term stability due to improved financial benchmarks. Strategic investments in technology and home care will boost growth, reduce costs, and improve margins through enhanced member health and retention.

View narrative

US$4.75

29.5% undervalued

22.16%

Revenue growth p.a.

6 days ago

Organogenesis Holdings

AnalystConsensusTarget

Consensus Narrative from 4 Analysts

LCD Delays And ReNu Progress Will Unlock Market Potential

Key Takeaways Delay in LCDs implementation offers a chance to capitalize on demand, boosting near-term revenue and market share for key products. Investments in clinical data and policy shifts could enhance reimbursement, access, and margins, driving sustained revenue growth and expansion in new markets.

View narrative

US$6.00

13.3% undervalued

9.16%

Revenue growth p.a.

6 days ago

Taboola.com

AnalystConsensusTarget

Consensus Narrative from 4 Analysts

Realize Platform And AI Will Expand Advertising Horizons

Key Takeaways Expansion into the broader performance advertising market and partnerships with major advertisers could drive revenue growth through increased client demand and effective use of AI. Financial flexibility from cash flow growth and share buyback expansion signals effective cost management and confidence, positively impacting margins and shareholder returns.

View narrative

US$3.96

22.0% undervalued

7.82%

Revenue growth p.a.

6 days ago

Stanley Black & Decker

AnalystConsensusTarget

Consensus Narrative from 16 Analysts

Supply Chain Upgrades And DEWALT Will Secure Progress In 2025

Key Takeaways Strategic transformation and operational excellence are expected to improve net margins while targeting substantial cost savings. Supply chain optimizations and innovation investment are anticipated to drive organic growth and mitigate tariff impacts.

View narrative

US$91.77

35.7% undervalued

2.54%

Revenue growth p.a.

6 days ago

Travere Therapeutics

AnalystConsensusTarget

Consensus Narrative from 15 Analysts

Expanded Approvals Will Broaden IgAN And FSGS Treatment Options

Key Takeaways FILSPARI's expanded approval and ongoing studies position it for increased revenue from treating renal diseases, with potential market expansion from the new sNDA submission for FSGS. Progress in the pegtibatinase program and possible REMS changes offer growth opportunities through new revenue streams and enhanced market penetration and retention.

View narrative

US$33.67

40.7% undervalued

47.99%

Revenue growth p.a.

6 days ago

HelloFresh

AnalystConsensusTarget

Consensus Narrative from 15 Analysts

Cost Reductions And Diversified Offerings Will Secure Future Operational Strength

Key Takeaways Efficiency programs and cost reductions aim to boost net margins and cash flow, improving unit economics and fixed costs. Strategic investments in customer offerings and product diversification target revenue growth via market expansion and increased order value.

View narrative

€11.74

20.3% undervalued

0.24%

Revenue growth p.a.

6 days ago

Community

Weekly Picks

Groundbreaking therapies that could change the treatment landscape for PTSD, fibromyalgia, MS & Alzheimer’s

DigitalOcean Will Grow 14% by Embracing AI with Paperspace Acquisition

Viant Technology: A Rising AdTech Challenger in the AI-Powered CTV Market

DOE Backed Ethanol-to-Jet And SaaS Projects Will Build Future Value

High-Performance Data Centers And AI Demand Will Fuel Success

Worsley Approvals And GEMCO Restart Will Strengthen Mining Operations

Tech-Driven Care And Home Services Will Secure Long-Term Success

LCD Delays And ReNu Progress Will Unlock Market Potential

Realize Platform And AI Will Expand Advertising Horizons

Supply Chain Upgrades And DEWALT Will Secure Progress In 2025

Expanded Approvals Will Broaden IgAN And FSGS Treatment Options

Cost Reductions And Diversified Offerings Will Secure Future Operational Strength

Value any company in seconds

Popular companies

Community

Weekly Picks

Groundbreaking therapies that could change the treatment landscape for PTSD, fibromyalgia, MS & Alzheimer’s

DigitalOcean Will Grow 14% by Embracing AI with Paperspace Acquisition

Viant Technology: A Rising AdTech Challenger in the AI-Powered CTV Market

Community Investing Ideas

DOE Backed Ethanol-to-Jet And SaaS Projects Will Build Future Value

High-Performance Data Centers And AI Demand Will Fuel Success

Worsley Approvals And GEMCO Restart Will Strengthen Mining Operations

Tech-Driven Care And Home Services Will Secure Long-Term Success

LCD Delays And ReNu Progress Will Unlock Market Potential

Realize Platform And AI Will Expand Advertising Horizons

Supply Chain Upgrades And DEWALT Will Secure Progress In 2025

Expanded Approvals Will Broaden IgAN And FSGS Treatment Options

Cost Reductions And Diversified Offerings Will Secure Future Operational Strength

Value any company in seconds

Popular companies